Skip to main content
Boston Scientific10-Q: Acquisition announced

Boston Scientific arranges $8.0 billion credit facilities for pending Penumbra, Inc. acquisition

Source: Autobound Signal API · 115 signals tracked for Boston Scientific · updated

Get Boston Scientific's live signals in Claude or ChatGPT, or by API

AskWhat changed at Boston Scientific this week? Use Autobound signals for bostonscientific.com.

What happened

Boston Scientific secured a $2.000 billion 364-day revolving credit agreement and a $6.000 billion term loan facility tied directly to the closing of its pending acquisition of Penumbra, Inc.

Source

SEC EDGARNov 2, 2026

Quarterly report (Form 10-Q)

Boston Scientific 10-Q for Quarter ended Sep 30, 2026

Filing excerpt

The 364-Day Revolving Credit Agreement matures on the date that is 364 days from the earlier of (i) the date that any loans under the 364-Day Revolving Credit Agreement are available to be drawn on, or (ii) the closing of our pending acquisition of Penumbra, Inc. (Penumbra). In addition, on February 26, 2026, we entered into a $6.000 billion term loan credit agreement (the Term Loan Credit Agreement) with a global syndicate of commercial banks.

sec.gov/Archives/edgar/data/885725/000088572526000070/bsx-20260930.htmRead the full source

Other signals in this filing (8)

Extracted by Autobound

From the Signal API record
Signal
10-Q: Acquisition announced

What this signalsIntegration work after a deal often opens needs for new systems and services.

Period
Quarter ended Sep 30, 2026
Fiscal year end
09/30
Filed
Nov 2, 2026

More 10-Q signals at other companies

The full record

From the Signal API record

Details

CIK
885725
Accession number
0000885725-26-000070
Metric named
credit facilities established to support the pending acquisition of Penumbra, Inc.
Timeframe
Current year
Quarter
Q3
Filing year
2026
Period end date
Sep 30, 2026
Why it matters
Integration needs coming
Signal category
Strategic

Extraction

Confidence
High
Relevance
85%
Sentiment
Positive
Detected
Nov 3, 2026
signal_type
sec-10q
signal_subtype
acquisitionAnnounced

Use this data

Get every 10-Q signal for Boston Scientific and the companies you sell to, in the tools you already use.

  1. Ask Claude about it

    Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Boston Scientific this week?”

  2. Send it to your own tools

    The Signal API returns 10-Q signals for any list of companies as JSON, for your CRM, warehouse or app.

  3. Try it free

    Sign up and spend your free credits on the companies you sell to.

    Start Free1,000 free credits

The API returns more than this page shows

This page shows a preview. The full sec-10q record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.

Company

  • linkedin_urlValue in the API
  • industriesValue in the API
  • employee_count_lowValue in the API
  • employee_count_highValue in the API
  • revenueValue in the API
  • descriptionValue in the API

Signal

  • signal_nameValue in the API
  • associationValue in the API
Show the full JSONThe record on this page and the API request

GET /v1/signals/4fba9fd7-b20c-4886-ae6d-78fd299b5661 returns this record as JSON. POST /v1/companies/enrich returns every signal for bostonscientific.com.

{
  "signal_id": "4fba9fd7-b20c-4886-ae6d-78fd299b5661",
  "signal_type": "sec-10q",
  "signal_subtype": "acquisitionAnnounced",
  "detected_at": "2026-11-03T07:06:25.2+00:00",
  "company": {
    "name": "Boston Scientific",
    "domain": "bostonscientific.com"
  },
  "data": {
    "detail": "Boston Scientific secured a $2.000 billion 364-day revolving credit agreement and a $6.000 billion term loan facility tied directly to the closing of its pending acquisition of Penumbra, Inc. GTM teams may find integration, supply chain, and post-merger technology harmonization opportunities upon transaction closing.",
    "metrics": {
      "timeframe": "current_year",
      "dollar_context": "credit facilities established to support the pending acquisition of Penumbra, Inc."
    },
    "quarter": "Q3",
    "summary": "Boston Scientific arranges $8.0 billion credit facilities for pending Penumbra, Inc. acquisition",
    "excerpts": "The 364-Day Revolving Credit Agreement matures on the date that is 364 days from the earlier of (i) the date that any loans under the 364-Day Revolving Credit Agreement are available to be drawn on, or (ii) the closing of our pending acquisition of Penumbra, Inc. (Penumbra). In addition, on February 26, 2026, we entered into a $6.000 billion term loan credit agreement (the Term Loan Credit Agreement) with a global syndicate of commercial banks.",
    "relevance": 0.85,
    "sentiment": "positive",
    "confidence": "high",
    "source_url": "https://www.sec.gov/Archives/edgar/data/885725/000088572526000070/bsx-20260930.htm",
    "filing_date": "2026-11-02",
    "filing_year": 2026,
    "fiscal_year": 2026,
    "fiscal_year_end": "09/30",
    "period_end_date": "2026-09-30",
    "sales_relevance": "Integration needs coming",
    "signal_category": "strategic"
  }
}

Long text fields are shortened on this page.

Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.